Early Clinical Experience of CD19 x CD22 Dual Specific CAR T Cells for Enhanced Anti-Leukemic Targeting of Acute Lymphoblastic LeukemiaRebecca Gardner, Michael C. Jensen, Kaelin Crews et al.|Blood|2018Cited by 65
SCRI-CAR19x22v2 T Cell Product Demonstrates Bispecific Activity in B-ALLColleen Annesley, Rebecca Gardner, Corinne Summers et al.|Blood|2021Cited by 22
Pediatric and young adult leukemia adoptive therapy (PLAT)-08: A phase 1 study of SC-DARIC33 in pediatric and young adults with relapsed or refractory CD33+ AML.Todd M. Cooper, Rebecca Gardner, Vicky Wu et al.|Journal of Clinical Oncology|2022Cited by 8